Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing
Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing
Not yet recruiting · NCT07462533 · Registry updated 2026-03-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Facies, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, skin disorder | Not yet recruiting | Phase 2 | 2026-03-10 | NCT07462533 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bai Biosciences | 1 |
| Goldman, Butterwick, Fitzpatrick and Groff | 11 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||